Interpace Diagnostics®, with almost 70,000 tests performed, is a leading provider of advanced molecular diagnostic testing for the risk-stratification of pancreatic cysts, solid tumors, and biliary strictures. The Company offers two report options of PathFinderTG® to aid gastroenterologists in determining cancer risk and help inform patient management decisions: PancraGEN®, a fully integrated reporting of first-line tests and procedures with molecular test results, and PanDNA®, a molecular-only reporting option for physician integration and interpretation of all test results.
Interpace Diagnostics
2001 Route 46 Waterview Plaza
Suite 310
Parsippany, NJ 07054